TransCatheter Aortic Valves Market
Medtech Ventures, February 2013, Pages: 32
The global transcatheter aortic heart valve opportunity continues to be strong and growing. Edwards reported 2012 sales of $552 and predicts it will manage to generate $780 million globally in 2013, including $420 million in the US alone. Our analysts forecast a $2.2 billion global market by 2018.
Interventional cardiologists are exceptionally enthusiastic about the potential of transcatheter aortic valve replacement, and with good reason. The preliminary data on this new treatment modality show that the procedure provides a minimally invasive alternative to cardiac valve surgery.
The average age for patients diagnosed with severe aortic stenosis is 70 years. Traditional valve replacement is considered a high risk surgery for most of these elderly patients.
Furthermore, a significant percentage of patients diagnosed with moderate or severe valve disease have been denied traditional valve surgery, due to its high operative mortality rate.
Transcatheter aortic valve implantation (TAVI) has been established as an alternative to surgical aortic valve replacement in inoperable and high-risk patients with severe, symptomatic aortic stenosis.
Next-generation transcatheter aortic valves will facilitate the procedure, improve outcome and usability and address remaining TAVI-specific drawbacks such as periprosthetic aortic regurgitation.
The TransCatheter Aortic Valves Market report is targeted at senior executives in the medical device industry who wish to get up-to-date with this multi-billion dollar fast growing market. The report offers a consensus-based linear forecast to to 2018.
1. Executive Summary
2. Aortic Stenosis
2.1 Background, Pathophysiology & Diagnosis
2.2 Current Treatment Options
2.3 Medical Therapy
2.4 Balloon Aortic Valvuloplasty
2.5 Surgical Aortic Valve Replacement
2.5.1 Mechanical Valves
2.5.2 Bioprosthetic Valves
2.6 Endovascular Aortic Valve Repair
3. TransCatheter Aortic Valve Technology
3.1 History & Background
3.2 Balloon-Expandable TransCatheter Aortic Valves
3.3 Self-Expandable TransCatheter Aortic Valve
3.4 TransCatheter Aortic Valve Implantation Procedure
3.4.1 TransFemoral Approach
3.4.2 TransApical Approach
3.4.3 TransAortic Approach
3.4.4 Subclavian Approach
3.4.5 TransAxillary Approach
3.4.6 Valve Placement
3.5 Hemodynamics of TransCatheter Valves
3.6 Clinical Trials Update
4. TransCatheter Aortic Valves Market
4.1 Market Revenue & Growth Trends
4.2 Commercially Available TransCatheter Aortic Valves
4.2.1 Acurate Aortic Valve - Symetis
4.2.2 CoreValve - Medtronic
4.2.3 JenaValve
4.2.4 Portico Aortic Valve – St. Jude Medical
4.2.5 Sapien Valve - Edwards Lifesciences
4.3 Geographical Segmentation
4.4 Leading Companies Market Shares
5. The Future of TransCatheter Aortic Valves
5.1 Market Potential
5.2 Next Generation TransCatheter Aortic Valves
5.2.1 Direct Flow Aortic Valve - Direct Flow Technology
5.2.2 Engager Aortic Valve - Medtronic
5.2.3 Lotus Aortic Valve – Boston Scientific
5.2.4 VXi Exchangeable Valve System - ValveXchange
5.2.5 Other In-Development TransCatheter Aortic Valves
5.3 Market Forecast
6. Company in the Space
6.1 Boston Scientific
6.2 Bracco Group
6.3 Braile Biomedica
6.4 Direct Flow Medical
6.5 Edwards Lifesciences
6.6 Hansen Medical
6.7 JenaValve
6.8 Medtronic
6.9 St. Jude Medical
6.10 Symetis
6.11 ValveXchange
List of Tables & Figures:
1. TransCatheter Aortic Heart Valves Market Revenue & Growth Trend (2007 – 2012)
2. TransCatheter Aortic Valves Market - Geographic Segmentation (2012)
3. TransCatheter Aortic Valves Market - Leading Companies Market Share (2012)
4. TransCatheter Aortic Valves Market Forecast (2013 – 2018)
Product Samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW6
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
